Regenerative Medical Solutions Inc.

Regenerative Medical Solutions, Inc. is a privately owned biotechnology company with roots in Madison, Wisconsin, and Chicago, Illinois, dedicated to advancing stem cell research, pancreatic islet biology, and islet transplantation. The team brings a strong blend of entrepreneurship and product development to collaborations with leading researchers and global biotech partners, helping move scientific ideas toward real-world impact in regenerative medicine. At the core of this work is a clear mission: translate discoveries into therapies that meaningfully improve patient outcomes. The company’s ILC Cell Kits are designed to support rigorous research workflows and accelerate progress in labs focused on islet lineage and related applications. Through strategic partnerships and a commitment to quality, the company enables investigators to explore new directions in cellular biology and transplantation science. With a focus on thoughtful innovation and responsible science, the organization continues to build bridges between discovery and application while contributing to a stronger, more connected research community.